Evaluation of the training program for p16/Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry

Evaluation of the training program for p16/Ki-67 dual staining interpretation

  • Veronika Kloboves Department of Cytopathology, Institute of Oncology, Ljubljana, Slovenia
  • Živa Pohar Marinšek Department of Cytopathology, Institute of Oncology, Ljubljana, Slovenia
  • Janja Zalar Department of Cytopathology, Institute of Oncology, Ljubljana, Slovenia
  • Hermina Rozina Department of Cytopathology, Institute of Oncology, Ljubljana, Slovenia
  • Nika Kotnik Carl von Ossietzky Universität, Department of Experimental Allergology and Immunodermatology Oldenburg, Oldenburg, Germany
  • Tine Jerman ZORA National Cervical Cancer Screening Programme and Registry, Epidemiology and Cancer Registry, Institute of Oncology, Ljubljana, Slovenia
  • Jerneja Varl Institute of Oncology, Dept. of Experimental Oncology, Ljubljana, Slovenia; University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia
  • Urška Ivanuš ZORA National Cervical Cancer Screening Programme and Registry, Epidemiology and Cancer Registry, Institute of Oncology, Ljubljana, Slovenia

Abstract

Background: p16/Ki-67 dual immunocytochemical staining (DS) is considered easy to interpret if evaluators are properly trained, however, there is no consensus on what constitutes proper training. In the present study we evaluated a protocol for teaching DS evaluation on students inexperienced in cervical cytology.

Methods: Initial training on 40 DS conventional smears was provided by a senior cytotechnologist experienced in such evaluation. Afterwards, two students evaluated 118 cases. Additional training consisted mainly of discussing discrepant cases from the first evaluation and was followed by evaluation of new 383 cases. Agreement and accuracy of students’ results were compared among the participants and to the results of the reference after both evaluations. We also noted time needed for evaluation of one slide as well as intra-observer variability of the teacher’s results.

Results: At the end of the study, agreement between students and reference was higher compared to those after initial training (OPA 81.4% for each student, kappa 0.512 and 0.527 vs OPA 78.3% and 87.2%, kappa 0.556 and 0.713). However, accuracy results differed between the two students. After initial training sensitivity was 4.3% points and 2.9% points higher, respectively compared to the reference, while specificity was 30.6% points and 24.4% points lower, respectively, compared to the reference. At the end of the study, the sensitivity reached by one student was the same as that of the reference, while it was 2.6% points lower for the other student. There was a statistically significant difference in specificity between one student and the reference and also between students (16.7 and 15.1% points). Towards the end of the study, one student needed 5.2 min for evaluating one slide while the other needed 8.2 min. The intra-observer variability of the senior cytotechnologist was in the range of “very good” in both arms of the study.

Conclusion: In teaching DS evaluation, the students’ progress has to be monitored using several criteria like agreement, accuracy and time needed for evaluating one slide. The monitoring process has to continue for a while after students reach satisfactory results in order to assure a continuous good performance. Monitoring of teacher’s performance is also advisable.

Key words: training protocol, p16/Ki-67 dual immunocytochemical staining, agreement, accuracy, inter-observer reproducibility

Published
2020-05-31
How to Cite
Kloboves, V., Pohar Marinšek, Živa, Zalar, J., Rozina, H., Kotnik, N., Jerman, T., Varl, J., & Ivanuš, U. (2020). Evaluation of the training program for p16/Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry . Radiology and Oncology, 54(2), 201-208. Retrieved from https://radioloncol.com/index.php/ro/article/view/3398
Section
Clinical oncology